Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 23260059)

1.

Seroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore.

Trauer JM, Bandaranayake D, Booy R, Chen MI, Cretikos M, Dowse GK, Dwyer DE, Greenberg ME, Huang QS, Khandaker G, Kok J, Laurie KL, Lee VJ, McVernon J, Walter S, Markey PG; Australia, New Zealand and Singapore Pandemic Serosurveillance Study Group.

Emerg Infect Dis. 2013 Jan;19(1):92-101. doi: 10.3201/eid1901.111643.

2.

Differential effects of pandemic (H1N1) 2009 on remote and indigenous groups, Northern Territory, Australia, 2009.

Trauer JM, Laurie KL, McDonnell J, Kelso A, Markey PG.

Emerg Infect Dis. 2011 Sep;17(9):1615-23. doi: 10.3201/eid1709.101196.

3.

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.

Hardelid P, Andrews NJ, Hoschler K, Stanford E, Baguelin M, Waight PA, Zambon M, Miller E.

Health Technol Assess. 2010 Dec;14(55):115-92. doi: 10.3310/hta14550-03.

4.

Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011.

Hoschler K, Thompson C, Andrews N, Galiano M, Pebody R, Ellis J, Stanford E, Baguelin M, Miller E, Zambon M.

Emerg Infect Dis. 2012 Nov;18(11):1894-7. doi: 10.3201/eid1811.120720.

5.

Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.

Van Kerkhove MD, Hirve S, Koukounari A, Mounts AW; H1N1pdm serology working group.

Influenza Other Respir Viruses. 2013 Sep;7(5):872-86. doi: 10.1111/irv.12074. Epub 2013 Jan 21. Review.

PMID:
23331969
6.

Post-pandemic seroprevalence of 2009 pandemic influenza A (H1N1) virus in Shandong Province, China.

Liu T, Li Z, Song S, Zhang S, Wang Y, Lin Y, Wang S, Wang X, Xu A, Bi Z.

Jpn J Infect Dis. 2012;65(5):410-4.

7.

Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter.

Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, Dwyer DE.

PLoS One. 2010 Sep 7;5(9):e12562. doi: 10.1371/journal.pone.0012562.

8.

Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.

Tandale BV, Pawar SD, Gurav YK, Chadha MS, Koratkar SS, Shelke VN, Mishra AC.

BMC Infect Dis. 2010 Aug 25;10:255. doi: 10.1186/1471-2334-10-255.

9.

Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.

McVernon J, Laurie K, Faddy H, Irving D, Nolan T, Barr I, Kelso A.

Influenza Other Respir Viruses. 2014 Mar;8(2):194-200. doi: 10.1111/irv.12225. Epub 2013 Dec 31.

10.

Seropositivity for influenza A(H1N1)pdm09 virus among frontline health care personnel.

Alagappan K, Silverman RA, Hancock K, Ward MF, Akerman M, Dawood FS, Branch A, De Cicco S, Steward-Clark E, McCullough M, Tenner K, Katz JM.

Emerg Infect Dis. 2013 Jan;19(1):140-3. doi: 10.3201/eid1901.111640.

11.

A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore.

Barr IG, Cui L, Komadina N, Lee RT, Lin RT, Deng Y, Caldwell N, Shaw R, Maurer-Stroh S.

Euro Surveill. 2010 Oct 21;15(42). pii: 19692.

12.

Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009.

McVernon J, Laurie K, Nolan T, Owen R, Irving D, Capper H, Hyland C, Faddy H, Carolan L, Barr I, Kelso A.

Euro Surveill. 2010 Oct 7;15(40). pii: 19678.

13.

Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic.

Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, Baker MG, Beasley R, Reid S, Roberts S, Hope V; 2009 H1N1 Serosurvey Investigation Team.

PLoS One. 2010 Oct 14;5(10):e13211. doi: 10.1371/journal.pone.0013211.

14.

Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.

Delangue J, Salez N, Ninove L, Kieffer A, Zandotti C, Seston M, Lina B, Nougairede A, Charrel R, Flahault A, de Lamballerie X.

Clin Microbiol Infect. 2012 Feb;18(2):177-83. doi: 10.1111/j.1469-0691.2011.03545.x. Epub 2011 Jun 2.

15.

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

ANZIC Influenza Investigators, Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, Cretikos M, Davies AR, Finfer S, Harrigan PW, Hart GK, Howe B, Iredell JR, McArthur C, Mitchell I, Morrison S, Nichol AD, Paterson DL, Peake S, Richards B, Stephens D, Turner A, Yung M.

N Engl J Med. 2009 Nov 12;361(20):1925-34. doi: 10.1056/NEJMoa0908481. Epub 2009 Oct 8.

16.

Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians.

Booy R, Khandaker G, Heron LG, Yin J, Doyle B, Tudo KK, Hueston L, Gilbert GL, Macintyre CR, Dwyer DE.

Med J Aust. 2011 Jan 3;194(1):19-23.

PMID:
21449863
17.

Pandemic H1N1 in children requiring intensive care in Australia and New Zealand during winter 2009.

Yung M, Slater A, Festa M, Williams G, Erickson S, Pettila V, Alexander J, Howe BD, Shekerdemian LS; Australia and New Zealand Intensive Care Influenza Investigators and the Paediatric Study Group and the Clinical Trials Group of the Australia New Zealand Intensive Care Society.

Pediatrics. 2011 Jan;127(1):e156-63. doi: 10.1542/peds.2010-0801. Epub 2010 Dec 20.

18.

Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

Skowronski DM, Hottes TS, McElhaney JE, Janjua NZ, Sabaiduc S, Chan T, Gentleman B, Purych D, Gardy J, Patrick DM, Brunham RC, De Serres G, Petric M.

J Infect Dis. 2011 Jan 15;203(2):158-67. doi: 10.1093/infdis/jiq039.

19.

Trends in seroprevalence of antibodies to pandemic influenza H1N1 (2009) virus among patients seeking care in China.

Xu C, Bai T, Wang M, Chen T, Wang L, Chen M, Zeng Y, Fan Ch, Yuan F, Shi J, Sun S, Li D, Wang S, Feng Z, Zhang Y, Yu H, Yang W, Wang Y, Shu Y.

Acta Virol. 2012;56(4):329-35.

PMID:
23237089
20.

Limited prevalence of influenza A/H1N1v antibodies: footprints of the pandemic of 2010.

Reinheimer C, Allwinn R, Doerr HW.

Infection. 2011 Apr;39(2):101-4. doi: 10.1007/s15010-011-0105-9. Epub 2011 Mar 22.

PMID:
21424756
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk